购物车
您的购物车当前为空
VEGFR-2-IN-81 是一种噻唑基异喹啉-1 (2H)-酮衍生物及VEGFR-2抑制剂,IC50为1.94 μM;其对结直肠癌细胞具有显著选择性细胞毒性,IC50=7.75 μM。VEGFR-2-IN-81 通过诱导细胞凋亡 (apoptosis)、升高细胞内ROS水平及降低线粒体跨膜电位发挥抗结直肠癌活性,并可用于结直肠癌、肺癌、乳腺癌和肝癌相关研究。
VEGFR-2-IN-81 是一种噻唑基异喹啉-1 (2H)-酮衍生物及VEGFR-2抑制剂,IC50为1.94 μM;其对结直肠癌细胞具有显著选择性细胞毒性,IC50=7.75 μM。VEGFR-2-IN-81 通过诱导细胞凋亡 (apoptosis)、升高细胞内ROS水平及降低线粒体跨膜电位发挥抗结直肠癌活性,并可用于结直肠癌、肺癌、乳腺癌和肝癌相关研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | VEGFR-2-IN-81 is a thiazole-based isoquinolin-1(2H)-one derivative that acts as a VEGFR-2 inhibitor with an IC50 of 1.94 μM. It demonstrates significant selective cytotoxicity against colorectal cancer cells (IC50= 7.75 μM). The compound exerts its anti-colorectal cancer effects by inducing apoptosis, increasing intracellular ROS levels, and reducing mitochondrial membrane potential. VEGFR-2-IN-81 is useful in research related to colorectal cancer, lung cancer, breast cancer, and liver cancer. |
| 靶点活(IC₅₀) | VEGFR2:1.94 μM |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多